BioSpace News Archive

Genetown

Astria Therapeutics to Participate in Virtual Fireside Chat at Upcoming H.C. Wainwright 1st Annual Hereditary Angioedema Conference

Astria Therapeutics to Participate in Virtual Fireside Chat at Upcoming H.C. Wainwright 1st Annual Hereditary Angioedema Conference.

July 14, 2022
·
1 min read
Business

Apertura Appoints Gene Therapy Executive Joseph La Barge as Chief Executive Officer

Apertura Gene Therapy , a biotechnology company leveraging its novel platform technologies for developing genetic medicines to treat debilitating diseases, today announced the appointment of gene therapy executive Joseph La Barge as Chief Executive Officer.

July 14, 2022
·
3 min read
Healthcare Data Storage Market Emerging Players May Yields New Opportunities 2021-2031

Wilmington, Delaware, United States, Transparency Market Research Inc.: Surge in the data generated by healthcare organizations around the world is likely to push the demand opportunities in the global healthcare data storage market during the forecast period of 2021 to 2031.

July 14, 2022
·
5 min read
Gynecology Drugs Market to be Driven by Rising Incidence and Prevalence Rate of Gynecological Diseases

Wilmington, Delaware, United States, Transparency Market Research Inc.: Gynecological diseases represent a collective term given to different medical conditions specific to the female reproductive system.

July 14, 2022
·
7 min read
Diagnostic Imaging Market: Competitive Research and Precise Outlook 2018 to 2026

Wilmington, Delaware, United States, Transparency Market Research Inc.: The global diagnostic imaging market is expected to grow at a robust 6.0% CAGR during 2018-2026.

July 14, 2022
·
4 min read
Implantable Medical Devices Market is Driven by Rise in Demand for Minimally Invasive Procedures

Wilmington, Delaware, United States, Transparency Market Research Inc.: The key growth drivers for the global implantable medical devices market include factors such as rising incidence of cardiovascular and neurological illnesses and aging population.

July 14, 2022
·
6 min read
Drug Development

Press Release: Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis

A Phase 3 trial assessing the investigational use of Dupixent® (dupilumab) in children aged 1 to 11 years with eosinophilic esophagitis (EoE) met its primary endpoint of histological disease remission at 16 weeks with both higher and lower dose weight-tiered regimens.

July 14, 2022
·
19 min read
Business

Orexo Interim Report Q2 2022

Orexo´s partner Gesynta Pharma’s drug candidate GS-248 (OX-MPI) granted Orphan Drug Designation in the US by the FDA for the treatment of systemic sclerosis

July 14, 2022
·
3 min read
Nanoform and Pharmanovia to breathe new life into iconic medicines

Nanoform Finland Plc., an innovative nanoparticle medicine-enabling company, announced that it has partnered with Pharmanovia, a fast-growing specialty pharma business with a portfolio of over 20 branded drugs in 140 markets.

July 14, 2022
·
3 min read
Theratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designated TH1902 First-in-Human Study in Advanced Resistant Malignancies

Theratechnologies Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies, provided an update on the dose escalation portion of the TH1902 Phase 1 clinical safety study.

July 14, 2022
·
9 min read